Latest Research Posts

ML141 (CID-2950007) ML141 Rho GTPase Inhibition Suppresses GAL3-Induced Neuronal Autophagy
ML141 (CID-2950007) ML141 Rho GTPase Inhibition Suppresses GAL3-Induced Neuronal Autophagy
Ro5126766, CH5126766 from Selleck (Avutometinib) Suppresses RAF MEK Signaling in LGSOC Models
Ro5126766, CH5126766 from Selleck (Avutometinib) Suppresses RAF MEK Signaling in LGSOC Models
Napabucasin (BBI608) Inhibits STAT3 Phosphorylation and Translation Initiation in Osteosarcoma
Napabucasin (BBI608) Inhibits STAT3 Phosphorylation and Translation Initiation in Osteosarcoma
Epoxomicin (BU-4061T) and Epoxomicin from Selleck target proteasomes in rat ventricles
Epoxomicin (BU-4061T) and Epoxomicin from Selleck target proteasomes in rat ventricles
Mitoxantrone Dihydrochloride (NSC 301739) Mitoxantrone Dihydrochloride inhibitor interaction with ds-DNA base pairs
Mitoxantrone Dihydrochloride (NSC 301739) Mitoxantrone Dihydrochloride inhibitor interaction with ds-DNA base pairs
AS1517499 STAT inhibitor Regulates STAT6 Phosphorylation and NIS Expression in Graves Disease
AS1517499 STAT inhibitor Regulates STAT6 Phosphorylation and NIS Expression in Graves Disease
NSC 74859 (S3I-201) from Selleck Inhibits Poxvirus K7-Mediated Epigenetic and Immune Evasion Pathways
NSC 74859 (S3I-201) from Selleck Inhibits Poxvirus K7-Mediated Epigenetic and Immune Evasion Pathways
AOA (Aminooxyacetic acid) hemihydrochloride inhibits cystathionine-β-synthase to suppress colon cancer bioenergetics
AOA (Aminooxyacetic acid) hemihydrochloride inhibits cystathionine-β-synthase to suppress colon cancer bioenergetics
Celastrol (Tripterine) Attenuates Ischemia-Reperfusion Injury by Suppressing the HIF-1α/PDK1 Axis
Celastrol (Tripterine) Attenuates Ischemia-Reperfusion Injury by Suppressing the HIF-1α/PDK1 Axis
T0070907 antagonist targeting PPARγ restores bone formation in hypoxia-induced skeletal growth failure
T0070907 antagonist targeting PPARγ restores bone formation in hypoxia-induced skeletal growth failure
Irinotecan Hydrochloride Trihydrate targeting Topoisomerase I in neuroendocrine carcinoma therapy
Irinotecan Hydrochloride Trihydrate targeting Topoisomerase I in neuroendocrine carcinoma therapy
SKI-606 (Bosutinib) SKI606 Targeted BCR-ABL1 Kinase Inhibition and Adverse Pulmonary Profiles
SKI-606 (Bosutinib) SKI606 Targeted BCR-ABL1 Kinase Inhibition and Adverse Pulmonary Profiles
Entrectinib (Rxdx-101) Rxdx-101 Trk receptor targeting and cost-effectiveness in ROS1-positive NSCLC
Entrectinib (Rxdx-101) Rxdx-101 Trk receptor targeting and cost-effectiveness in ROS1-positive NSCLC
3TC, BCH189 Lamivudine (3TC, BCH-189) Regimens Mitigate Antiretroviral Bone Turnover Dynamics
3TC, BCH189 Lamivudine (3TC, BCH-189) Regimens Mitigate Antiretroviral Bone Turnover Dynamics